Legg-Calve-Perthes Disease
Conditions
Keywords
Kinesiotape, Taping, Pediatric pain, Hip joint, Physiotherapy
Brief summary
Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).
Detailed description
Kinesio taping is increasingly being used as a complement to musculoskeletal pain management. A randomized, double-blind, placebo-controlled clinical trial was conducted. Activity-related hip pain, passive and pain limited hip range of motion, gluteus medius muscle strength, function and balance were assessed.
Interventions
OTHERKinesiotaping
Two I-strips were used: 1. The first-third of one I-strip began at the posterior iliac crest, without tension as an anchor. Then the patient actively flexed and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension. 2. The first-third of the second I-strip was applied starting at the anterior iliac crest, without tension as an anchor. The patient actively extended and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension.
OTHERSham taping
A single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the hip.
Sponsors
Istanbul University - Cerrahpasa
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Having received unilateral LCPD diagnosis, * Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week, * Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance
Exclusion criteria
* Having a history of any other hip pathologies, * Having allergy to polyacrylate adhesive, * Having used analgesic medication within the previous three days.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Immediate Clinical Efficacy on Activity Related Hip | The change between T1 (baseline) to T2 (thirty minutes later from the application) | Horizontal 10 cm VAS (0, no pain; 10, the worst pain ever possible) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Immediate Clinical Efficacy on Hip Abduction ROM | The change between T1 (baseline) to T2 (thirty minutes later from the application) | goniometric range of motion (ROM) |
| Immediate Clinical Efficacy on Functional Task Durations | The change between T1 (baseline) to T2 (thirty minutes later from the application) | 10-meters walk task duration (sec) and 10-step climbing task duration (sec) |
| Immediate Clinical Efficacy on Balance test durations | The change between T1 (baseline) to T2 (thirty minutes later from the application) | One leg stance test duration (sec) and Tandem walk test duration (sec) |
| Immediate Clinical Efficacy on Gluteus medius muscle strength | The change between T1 (baseline) to T2 (thirty minutes later from the application) | muscle strength by handheld dynamometer (Ibs) |
Countries
Turkey (Türkiye)
Outcome results
None listed